Serge Saxonov - 09 Jun 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
09 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 18:31:49 UTC
Previous filing
02 Jun 2025
Next filing
26 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saxonov Serge Chief Executive Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov 11 Jun 2025 0001786720

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Gift $0 -1,000 -0.1% $0.000000 955,240 09 Jun 2025 Direct F1
holding TXG Class A Common Stock 27 09 Jun 2025 See footnote F2
holding TXG Class A Common Stock 89,825 09 Jun 2025 See footnote F3
holding TXG Class A Common Stock 213,250 09 Jun 2025 See footnote F4
holding TXG Class A Common Stock 58,000 09 Jun 2025 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects transfer of 88,955 shares to Sirius Trust and 35,430 shares to Y/S Pot Trust on June 5, 2025.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.